Patents by Inventor Jacques H. Abraini

Jacques H. Abraini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition comprising at least one thrombolytic agent (A) and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
    Patent number: 8435569
    Abstract: The present invention relates to a pharmaceutical composition comprising at least one thrombolytic agent (A), such as the human recombinant form of tissue-type plasminogen activator (rt-PA), and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon, and mixtures thereof, as a combined composition for simultaneous, separate or sequential use for treating ischemia. The present invention also relates to the use of at least one thrombolytic agent (A), such as the human recombinant form of tissue-type plasminogen activator (rt-PA), and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon, and mixtures thereof, for the preparation of a combined pharmaceutical composition for treating ischemia.
    Type: Grant
    Filed: April 30, 2008
    Date of Patent: May 7, 2013
    Assignee: NNOXE Pharmaceutiques Inc.
    Inventor: Jacques H. Abraini
  • PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE THROMBOLYTIC AGENT (A) AND AT LEAST ONE GAS (B) SELECTED FROM THE GROUP CONSISTING OF NITROUS OXIDE, ARGON, XENON, HELIUM, NEON
    Publication number: 20100278942
    Abstract: The present invention relates to a pharmaceutical composition comprising at least one thrombolytic agent (A), such as the human recombinant form of tissue-type plasminogen activator (rt-PA), and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon, and mixtures thereof, as a combined composition for simultaneous, separate or sequential use for treating ischemia. The present invention also relates to the use of at least one thrombolytic agent (A), such as the human recombinant form of tissue-type plasminogen activator (rt-PA), and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon, and mixtures thereof, for the preparation of a combined pharmaceutical composition for treating ischemia.
    Type: Application
    Filed: April 30, 2008
    Publication date: November 4, 2010
    Inventor: Jacques H. Abraini